Pancreatic Cancer Research

ResearcherBaylor College of MedicineNo recent work listed

Sheng Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0268-8593; OpenAlex author ID A5100394036. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 4

  1. ID1 marks the tumorigenesis of pancreatic ductal adenocarcinoma in mouse and human. First author DOI 10.1038/s41598-022-17827-3↗
  2. Recurrence and survival after surgery for pancreatic cancer with or without acute pancreatitis. Co-author DOI 10.3748/wjg.v25.i39.6006↗
  3. Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS-… Co-author DOI 10.1371/journal.pone.0068303↗
  4. Chimeric Trop2 virus-like particles: a potential immunotherapeutic approach against pancreatic cancer. First author DOI 10.1097/cji.0b013e318209ee72↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuanxin Tang · 1 shared paper, 2022 · strength 0.20
  2. Chunli Wu · 1 shared paper, 2022 · strength 0.20
  3. Qing Fan · 1 shared paper, 2022 · strength 0.20
  4. Xu-Bao Liu · 1 shared paper, 2019 · strength 0.11
  5. Chunlu Tan · 1 shared paper, 2019 · strength 0.11
  6. Yonghua Chen · 1 shared paper, 2019 · strength 0.11
  7. Qian Feng · 1 shared paper, 2019 · strength 0.11
  8. Qizhi Cathy Yao · 2 shared papers, 2011–2013 · strength 0.08
  9. Rafael A. Cubas · 2 shared papers, 2011–2013 · strength 0.08
  10. Changyi Chen · 2 shared papers, 2011–2013 · strength 0.08
  11. Lin-Kin Yong · 1 shared paper, 2013 · strength 0.04
  12. Min Li · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.